Maynard Um
-
-
-
-
-
-
-
Tempus AI test outperforms standard biomarkers in predicting immunotherapy
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Tempus AI Inc (TEM)
-
-
-
-
-
-
-
Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $98 at H.C. Wainwright
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $72 at TD Cowen
-
-
-
-
-
-
-
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

